Symptom management and self-care for peripheral neuropathy in HIV/AIDS

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 2, 2007, Pages 179-189

  Nicholas, P K ^a,r   Kemppainen, J K ^b   Canaval, G E ^c   Corless, I B ^a   Sefcik, E F ^d   Nokes, K M ^e   Bain, C A ^f   Kirksey, K M ^g   Eller, L Sanzero ^h   Dole, P J ⁱ   Hamilton, M J ^d   Coleman, C L ^j   Holzemer, W L ^f   Reynolds, N R ^k   Portillo, C J ^f   Bunch, E H ^l   Wantland, D J ^f   Voss, J ^m   Phillips, R ^e   Tsai, Y F ⁿ   Mendez, M Rivero ^o   Lindgren, T G ^f   Davis, S M ^p   Gallagher, D M ^q   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

^c UNIVERSIDAD DEL VALLE   (Colombia)

^d TEXAS A AND M UNIVERSITY CORPUS CHRISTI   (United States)

^e CITY UNIVERSITY OF NEW YORK   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BEN TAUB GENERAL HOSPITAL   (United States)

^h RUTGERS UNIVERSITY   (United States)

ⁱ Greenwich House   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k OHIO STATE UNIVERSITY   (United States)

^l UNIVERSITY OF OSLO   (Norway)

^m NATIONAL INSTITUTES OF HEALTH   (United States)

ⁿ CHANG GUNG UNIVERSITY   (Taiwan)

^o UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

^q New England AIDS Education and Training Center   (United States)

^r MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; CALCIUM; CANNABIS; MAGNESIUM; NON PRESCRIPTION DRUG; VITAMIN B GROUP;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUPUNCTURE; ADULT; AGED; ALCOHOL CONSUMPTION; ALTERNATIVE MEDICINE; ARTICLE; CIGARETTE SMOKING; CONSERVATIVE TREATMENT; EXERCISE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MASSAGE; MEDITATION; PALLIATIVE THERAPY; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; REFLEXOLOGY; REST; SELF CARE; WALKING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ATTITUDE TO HEALTH; COLOMBIA; DRUGS, NON-PRESCRIPTION; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE; PUERTO RICO; SELF CARE; SMOKING; TAIWAN; UNITED STATES;

EID: 33847079994     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120600971083     Document Type: Article

References (47)

1. Araujo, A.P., Nascimento, O.J., & Garcia, O.S. (2000). Distal sensory polyneuropathy in a cohort of HIV-infected children over five years of age. Pediatrics, 106, E35.
2. Berger, A.R., Schaumburg, H.H., Gourevitch, M.N., Freeman, K., Herskovitz, S., & Arezzo, J.C. (1999). Prevalence of peripheral neuropathy in injection drug users. Neuropathy, 53, 592-597.
3. Cameron, L.D. (2003). Anxiety, cognition and responses to health threats. In L. D. Cameron, & H. Leventhal (Eds.), The self-regulation of health and illness behavior (pp. 157-183). New York, NY: Routledge.
4. Cherry, C.L., Wesselingh, S.L., Lal, L., & McArthur, J.C. (2005). Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology, 65, 1778-1781.
5. Dal Pan, G.J., & McArthur, J.C. (1996). Neuroepidemiology of HIV infection. Neurologic Clinics, 14, 359-382.
6. Dorsey, S.G., & Morton, P.G. (2006). HIV peripheral neuropathy: Pathophysiology and clinical implications. American Association of Critical-Care Nurses Clinical Issues, 17, 30-36.
7. Ellis, R.J., Evans, S.R., Clifford, D.B., Moo, L.R., McArthur, J.C., Collier, A.C., et al. (2005). Clinical validation of the NeuroScreen. Journal of Neurovirology, 11, 503-511.
8. Estanislao, L.B., Morgello, S., & Simpson, D.M. (2005). Peripheral neuropathies associated with HIV and hepatitis C coinfection: A review. AIDS, 19(Suppl.), S135-S139.
9. Ferrari, S., Vento, S., Monaco, S., Cavallaro, T., Cainelli, F., Rizzuto, N., et al. (2006). Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clinic Proceedings, 81, 213-219.
10. Floeter, M.K., Civitello, L.A., Everett, C.R., Dambrosia, J., & Luciano, C.A. (1997). Peripheral neuropathy in children with HIV infection. Neurology, 49, 207-212.
11. Gerschenson, M., & Brinkman, K. (2004). Mitochondrial dysfunction in AIDS and its treatment. Mitochondrion, 4, 763-777.
12. Griswold, G.A., Evans, S., Spielman, L., & Fishman, B. (2005). Coping strategies of HIV patients with peripheral neuropathy. AIDS Care, 17, 711-720.
13. Hall, C.D., Snyder, C.R., Messenheimer, J.A., Wilkins, J.W., Robertson, W.T., & Robertson, K.R. (1991). Peripheral neuropathy in a cohort of human immunodeficiency virus-infected patients: Incidence and relationship to nervous system dysfunction. Archives of Neurology, 48, 1273-1274.
14. Harrison, M.J.G., & McArthur, J.C. (1995). AIDS and neurology. Edinburgh: Churchill Livingstone.
15. Holmes, W.C., & Shea, J.A. (1997). Performance of a new, HIV-AIDS-targeted quality of life (HAT-QoL) instrument in asymptomatic seropositive individuals. Quality of Life Research, 6, 561-571.
16. Holmes, W.C., & Shea, J.A. (1999). Two approaches to measuring quality of life in the HIV/AIDS population: HAT-QoL and MOS-HIV. Quality of Life Research, 8, 515-527.
17. Holzemer, W.L., Hudson, A., Kirksey, K.M., Hamilton, M.J., & Bakken, S. (2001). The revised Sign and Symptom Check-List for HIV (SSC-HIVrev). Journal of the Association of Nurses in AIDS Care, 12, 60-70.
18. Hulgan, T., Haas, D.W., Haines, J.L., Ritchie, M.D., Robbins, G.K., Shafer, R.W., et al. (2005). Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: An adult AIDS clinical trials group study. AIDS, 19, 1341-1349.
19. Lichtenstein, K.A., Armon, C., Baron, A., Moorman, A.C., Wood, K.C., Holmberg, S. D., & The HIV Outpatient Study Investigators (2005). Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clinical Infectious Diseases, 40, 148-157.
20. Liu, J.P., Manheimer, E., & Yang, M. (2005). Herbal medicines for treating HIV infection and AIDS. Cochrane Database of Systematic Reviews, Jul 20 (3), CD003937.
21. McArthur, J.H. (1998). The reliability and validity of the subjective peripheral neuropathy screen. Journal of the Association of Nurses in AIDS Care, 9, 84-94.
22. Moore, R.D., Wong, W.M., Keruly, J.C., & McArthur, J.C. (2000). Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS, 14, 273-278.
23. Morgello, S., Estanislao, L., Simpson, D., Geraci, A., Dirocco, A., Gerits, P., et al., & Manhattan HIV Brain Bank (2004). HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: The Manhattan HIV Brain Bank. Archives of Neurology, 61, 546-551.
24. Moyle, G.J., & Sadler, M. (1998). Peripheral neuropathy with nucleoside antiretroviral therapy: Risk factors, incidence and management. Drug Safety, 19, 481-494.
25. Nakagawa, M., Maruyama, Y., Sugita, H., & Osame, M. (1997). Nationwide survey of neurologic manifestations of acquired immunodeficiency syndrome in Japan. Internal Medicine, 36, 175-178.
26. Nicholas, P.K., Kemppainen, J., Holzemer, W.L., Nokes, K.M., Eller, L.S., Corless, I.B., et al. (2002). Self-care management for peripheral neuropathy in HIV/AIDS. AIDS Care, 14, 763-771.
27. Nunnally, J.C., & Bernstein, I.H. (1994). Psychometric theory. New York, NY: McGraw-Hill.
28. Paice, J.A., Ferrans, C.E., Lashley, F.R., Shott, S., Vizgirda, V., & Pitrak, D. (2000). Topical capsaicin in the management of HIV-associated peripheral neuropathy. Journal of Pain and Symptom Management, 19, 45-52.
29. Pandya, R., Krentz, H.B., Gill, M.J., & Power, C. (2005). HIV-related neurological syndromes reduce health-related quality of life. Canadian Journal of Neurological Sciences, 32, 201-204.
30. Parry, O., Mielke, J., Latif, A.S., Ray, S., Levy, L.F., & Siziya, S. (1997). Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurologica Scandinavica, 96, 218-222.
31. Price, R.W. (1996). Neurological complications of HIV infection. Lancet, 348, 445-452.
32. Saarto, T., & Wiffen, P.J. (2005). Antidepressants for neuropathic pain. Cochrane Database of Systematic Review, July 20 (3), CD005454.
33. Schifitto, G., McDermott, M.P., McArthur, J.C., Marder, K., Sacktor, N., Epstein, L., et al., & Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders (2002). Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology, 58, 1764-1768.
34. Schifitto, G., McDermott, M.P., McArthur, J.C., Marder, K., Sacktor, N., McClernon, D. R., et al., & The Nead Consortium. (2005). Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology, 64, 842-848.
35. Schooley, R.T. (1999). Longer-term immunologic effects and side effects of successful antiretroviral therapy. Clinical Infectious Diseases, 29, 12-18.
36. Senneff, J.A. (1999). Numb toes and aching soles. San Antonio, Texas: Medpress.
37. Simpson, D.M., & Olney, R.K. (1992). Peripheral neuropathies associated with HIV infection. Neurologic Clinics, 10, 685-711.
38. Simpson, D.M., & Tagliati, M. (1994). Neurologic manifestations of HIV infection. Annals of Internal Medicine, 121, 769-785.
39. Simpson, D.M., Tagliati, M., & Ramcharitar, S. (1994). Neurologic complications of AIDS: New concepts and treatments. Mount Sinai Journal of Medicine, 61, 484-491.
40. Singer, E.J., Zorilla, C., Fahy-Chandon, B., Chi, S., Syndulko, K., & Rourtellotte, W.W. (1993). Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study. Pain, 54, 15-19.
41. Swanson, B., Zeller, J.M., & Paice, J.A. (1998). HIV-associated distal symmetrical polyneuropathy: Clinical features and nursing management. Journal of the Association of Nurses in AIDS Care, 9, 77-80.
42. Tsai, Y.F., Hsiung, P.C., & Holzemer, W.L. (2003). Validation of a Chinese version of the Sign and Symptom Checklist for persons with HIV disease. Journal of Pain and Symptom Management, 25, 363-368.
43. Venkataramana, A.B., Skolasky, R.L., Creighton, J.A., & McArthur, J.C. (2005). Diagnostic utility of the subjective peripheral neuropathy screen in HIV-infected persons with peripheral sensory polyneuropathy. AIDS Reader, 15, 341-344, 348-349 and 354.
44. Verma, S., Estanislao, L., Mintz, L., & Simpson, D. (2004). Controlling neuropathic in HIV. Current HIV/AIDS Reports, 1, 136-141.
45. Verma, S., Estanislao, L., & Simpson, D. (2005). Controlling neuropathic pain in HIV: Epidemiology, pathophysiology and management. Central Nervous System drugs, 19, 325-334.
46. Wulf, E.A., Wang, A.K., & Simpson, D.M. (2000). HIV-associated peripheral neuropathy: Epidemiology, pathophysiology and treatment. Drugs, 59, 1251-1260 (abstract).
47. Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A. (2005). Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management, 29, 358-367.